A study on the therapeutic effects of Naringenin on NASH [96] showed that Naringenin improves hepatic steatosis, hepatic fibrosis, hepatic inflammation, and hepatic oxidative stress in NASH mice, and it suggests that Naringenin exerts its therapeutic effects through SIRT1. This evidence concerns the gene SIRT1 and fatty liver disease.